RARE EPS Estimates
Ultragenyx Pharmaceutical Inc.
$16.70
+$0.56(+3.47%)
39
Overall
40
Value
27
Tech
50
Quality
Market Cap
$1.70B
Volume
2.67M
52W Range
$12.73 - $39.89
Target Price
$25.10
RARE EPS estimates: the consensus estimate for Ultragenyx Pharmaceutical Inc.'s current fiscal year is -$3.21 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RARE EPS Estimates
- EPS estimate, current quarter
- $0.86
- EPS estimate, next quarter
- $-0.33
- EPS estimate, current year
- $-3.21
- EPS estimate, next year
- $0.93
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2018 | $-1.73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $16.70 | +3.5% | 2.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW